Top Story

FDA grants orphan drug designation to Triolimus for angiosarcoma

April 29, 2015

The FDA granted orphan drug designation to Triolimus for the treatment of patients with angiosarcoma, according to a press release from the drug’s manufacturer.

Triolimus (Co-D Therapeutics) is a combination of three complementary anti-cancer agents — paclitaxel, rapamycin and tanespimycin (17-AAG) — in a non-toxic carrier.

In the Journals

Long-term treatment with trabectedin extends PFS, OS in soft tissue sarcoma

March 13, 2015
Patients with soft tissue sarcoma who received trabectedin until disease progression demonstrated significantly improved PFS and OS compared with patients who only…
In the Journals

Targeted preoperative radiation reduces late toxicities in extremity sarcoma

March 4, 2015
The use of preoperative image-guided radiation therapy was associated with a reduction in late toxicities among patients with extremity soft tissue sarcoma, according to…
thumbnail for video 4083320513001 Meeting News CoverageVideo

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Chief Medical Editor Paul Volberding, MD, reviews HIV and cancer treatment data presented here at CROI 2015. Highlights include cervical cancer…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
FDA News

FDA grants orphan drug designation to Triolimus for angiosarcoma

April 29, 2015
The FDA granted orphan drug designation to Triolimus for the treatment of patients with angiosarcoma, according to a press release from the…
In the Journals

Long-term treatment with trabectedin extends PFS, OS in soft tissue sarcoma

March 13, 2015
Patients with soft tissue sarcoma who received trabectedin until disease progression demonstrated significantly improved PFS and OS compared with…
In the Journals

Targeted preoperative radiation reduces late toxicities in extremity sarcoma

March 4, 2015
The use of preoperative image-guided radiation therapy was associated with a reduction in late toxicities among patients with extremity soft tissue…
thumbnail for video 4083320513001 Meeting News CoverageVideo

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Chief Medical Editor Paul Volberding, MD, reviews HIV and cancer treatment data presented here at CROI 2015. Highlights…
In the Journals

Boosted PIs lower Kaposi sarcoma incidence

February 10, 2015
Recent data suggest longer duration of treatment with protease inhibitors boosted with Norvir was associated with a reduced incidence of Kaposi…
Maintaining public awareness is critical to solving the problem of drug shortages, according to J. Leonard Lichtenfeld, MD, MACP, deputy chief medical officer for the American Cancer Society. “If we don’t constantly revisit this and make people aware of it, then this will become the status quo,” he said. Cover StoryPublication Exclusive

Expectation of drug shortages has become ‘new norm’ for cancer care

HemOnc Today, February 10, 2015
More than 230 drugs appeared on the American Society of Health-System Pharmacists’ drug shortage list as of mid-January.The list — primarily…
FDA NewsDrug Pipeline

FDA grants priority review to Yondelis for treatment of advanced soft tissue sarcoma

February 3, 2015
The FDA has granted priority review to Yondelis for the treatment of patients with advanced soft tissue liposarcoma and leiomyosarcoma who have…
In the Journals

IG-IMRT showed favorable outcomes in skull base chordoma, chondrosarcoma

January 19, 2015
Patients with chordomas or chondrosarcomas of the skull base had favorable 5-year OS and local control after high-dose image-guided…
Meeting News Coverage

Preoperative transcutaneous oximetry predicted complications in sarcoma radiation

November 21, 2014
The use of preoperative transcutaneous oximetry may be useful in predicting wound-healing complications in patients undergoing surgery for soft…
FDA News

FDA grants fast track designation to TH-302 for metastatic soft tissue sarcoma

November 11, 2014
The FDA granted fast track designation to TH-302 as a potential treatment for previously untreated patients with metastatic or locally advanced…
More Headlines »
morganatic-roan